End of an Era: PCR Patent

WHAT the dominance of Microsoft Windows is to
personal computers, the dominance of the polymerase chain reaction
(PCR) is to biotechnology…
it has transferred large numbers of dollars
from the pockets of its users to those of its patent holder, F.
Hoffmann-La Roche. But on March 28th, the gravy train began to dry up.
The original patents on the technology expired in America (they expire
in March 2006 in Europe).

"Patent ending: The polymerase chain reaction" The Economist. London: Apr 9, 2005. Vol.375, Iss. 8421;  pg. 73 (subscription only)


AccessExcellence on PCR

The PCR Project at Berkeley

Videos on PCR at Roche


Comments are closed.